BIT's 6th Annual International Congress of Antibodies-2014
Highlights of the Conference
600+ Attendees Coming from All over the World to Exchange Ideas, Build New Networks, and Foster Friendships
200+ Presentations, 100+ Exhibition Booths and 50+ Scientific Posters Covering Science, Technology, Business, and Policy in the Field of Antibody
Joint Held with Other Seven Grand Conferences in Life Sciences, Hear the Voice from Several Nobel Laureates
Roundtable and Panel Discussion, Matchmaking, Investment, Career Development Opportunities
Social Activities and Networking, Field Trip and Tech-tour, Build Partnerships in China, Find Huge Opportunities and Markets for Your Business over the World
Event Overview
Following on the successful organizing of ICA-2013, we are pleased to announce the next ICA conference will be held during April 25-28, 2014 in Dalian, China. With the theme of "The New Era of Antibody Therapy and Research", we will once again offer professionals in the field of antibody a multidisciplinary informative platform.
Renowned Speakers   Dr. Ralf Ostendorp, Vice President, Protein Sciences, MorphoSys AG, Germany
+View Bio   Dr. Palani Palaniappan, Vice President & Global Head, Takeda Pharmaceutical Company, UK
+View Bio   Dr. Michael A. Swit, Vice President, The Weinberg Group Inc., USA
+View Bio
Dr Robert Friesen Vice President, Preclinical and Clinical Research, Compound Development Team Leader   Dr. Grant Shimamoto, Senior Scientist, Amgen, USA
+View Bio   Dr. Jijie Gu, Senior Principal Research Scientist, Global Biologics, AbbVie, USA
+View Bio
Dr Robert Friesen Vice President, Preclinical and Clinical Research, Compound Development Team Leader   Dr. Helle Markholst, Director, Novo Nordisk A/S, Denmark
+View Bio   Dr. Eva Kimby, Professor, Karolinska University Hospital, Sweden
+View Bio   Dr. Karlheinz Peter, Professor, Monash University, Australia
+View Bio
Dr Robert Friesen Vice President, Preclinical and Clinical Research, Compound Development Team Leader   Dr. Roman Prymula, Professor & Chairman, The Czech Immunisation Society, Czech Republic
+View Bio   Dr. Zhi Liu, Professor, University of North Carolina, USA
+View Bio   Dr. Mitchell Ho, Head, NIH, USA
+View Bio
  Dr. Stefan D. Magez, Professor, Vrije Universiteit Brussel, Belgium
+View Bio   Dr. Duncan D. Adams, Director, Faculty of Medicine, University of Otago, New Zealand
+View Bio
  Dr. Eric Smith, Associate Director, Regeneron, USA
+View Bio   Dr. Michael Vajdy, Co-Founder & Chief Scientific Officer, EpitoGenesis, Inc, USA
+View Bio   Dr. Uwe R. Muller, CSO, NeoClone, USA
+View Bio
Dr Robert Friesen Vice President, Preclinical and Clinical Research, Compound Development Team Leader   Dr. T. Nathan Yoganathan, President and CEO, KalGene Pharmaceuticals, USA
+View Bio   Dr. Myron Arlen, Director of Scientific Affairs, Precision Biologics, Inc., USA
+View Bio   Dr. Trent Carrier, Chief Business Officer, Biologics Consulting Group, Inc, USA
+View Bio
Dr Robert Friesen Vice President, Preclinical and Clinical Research, Compound Development Team Leader   Dr. Judith Santos, Senior Manager, Acorda Therapeutics, USA
+View Bio   Dr. David Humphreys, Director, UCB New Medicines, USA
+View Bio   Dr. Li Zhou, Head, Novartis Biologics, USA
+View Bio   Dr. Scott Gallichan, Director, Sanofi Pasteur, France
+View Bio   Dr. X. Kate Zhang, Senior Director, Genzyme Corporation, USA
+View Bio
List of attended Organization
Boehringer Ingelheim, Germany
Wanbang Biopharmaceutical Group, China
Isenbruck Bosl Horschler LLP, Germany
Acorda Therapeutics, USA
NeoClone, USA
Mount Sinai Medical Center, USA
Suzhou Shenogen Pharma Group Ltd., China
U-CyTech biosciences, The Netherlands Genzyme, USA
LFB Biotechnologies , France
Bayer, USA
AbbVie, USA
Regeneron, USA
Genzyme Corporation, USA
MorphoSys AG, Germany
Boost Technologies BV, Lelystad, The Netherlands
Genor BioPharma Co., Ltd, China
Melville Analytics Pty Ltd, Australia
Takeda Pharmaceutical Company, UK
Adagene, China
Avesthagen Limited, India
Zoetis New Zealand Ltd, New Zealand
Dako A/S, Denmark
Refine Technology, USA
KalGene Pharmaceuticals, USA
OriGene Technologies, Inc., USA
Novo Nordisk A/S, Denmark
BioArctic Neuroscience AB, Sweden
A-CONNECT, Switzerland
HuaBo Biopharm Co., Ltd., China
Emergent BioSolutions, USA
Mochida Pharmaceutical Co.,Ltd., Japan
Fabion Pharmaceuticals, Inc., USA
Amgen, USA
Novartis Biologics, USA
SAIC-Frederick Inc., USA
Evogenix Inc., USA
Lonza, Switzerland
Held Malloy, Ltd., USA
Goldstein Fox P.L.L.C., USA
RegPak BioPharma Consulting, Netherlands
Jaffe PR, USA
Neogenix Oncology Inc., USA
Sanofi Pasteur, France
Yale University School of Medicine, USA
University of California, USA
Johannes Gutenberg-University, Germany
Monash University, Australia
Museum national d'Histoire naturelle, France
York University, Canada
Monash University, Australia
National Research Council Canada, Canada
Technical University Dresden, Germany
Northeast Agricultural University, China
Southampton University, UK
Medical University of Innsbruck, Austria
National and Kapodistrian University of Athens, Greece
Washington University in St Louis, USA
Pomeranian Medical University of Szczecin, Poland
King Fahad Specialist Hospital, Saudi Arabia
Queens University Belfast, UK
The Forsyth Institute, USA
Hospital Clnic y Provincial de Barcelona, Spain
Portland State University, USA
Indian Institute of Technology, India
Tepecik Training and Research Hospital, Turkey
University of Rome "Sapienza", Italy
Karolinska University Hospital, Sweden
University of British Columbia, Canada
National Cancer Institute, USA
David Geffen School of Medicine at the University of California, USA
Johns Hopkins University, USA
Cardiff School of Biosciences, Cardiff University, UK
University of Hawaii, USA
VIT University, India
International Centre for Genetic Engineering Biotechnology, India
Shanghai Institute for Food and Drug Safety, China
Indraprastha Apollo Hospitals, India
University of North Carolina, USA
Queen's Hospital, UK
Indian Veterinary Research Institute, India
University of Rome, Italia
International Islamic University, Malaysia
Gyeongsang National University, Korea
University of Basel, Switzerland
National Institutes for Food and Drug Control, China
University Medicine of Berlin, Germany
Duke University School of Medicine, USA
Zhejiang Academy of Medical Science, China
Universidade Federal De Uberlandia, Brazil
Vrije Universiteit Brussel, Belgium
Northwest A&F UniversityChina
Conference Guide
Hosting Organizations
Information Research Center of
International Talents, SAFEA
Dalian Administration of Foreign
Experts Affairs
China Council for the Promotion of
International Trade
Dalian Sub-Council
Operating Organizations
BIT Congress ,Inc
Foreign Experts Databank of SAFEA-Dalian Biotechnological and Medical Experts Subdivision
Supporting Organization
China Committee of Corporate Citizenship
Official Travel Agent
BIT World Travel Service, Inc.

Dr. Hartmut Michel, Professor, Max Planck Institute, Germany

Nobel Prize laureate in Chemistry, 1988

Prize motivation: " for their determination of the three-dimensional structure of a photosynthetic reaction centre"

Dr. Theodor W. Hänsch, Director, the Max-Planck-Institut für Quantenoptik (quantum optics), Germany

Nobel Prize laureate in Physics, 2005

Prize motivation: " for their contributions to the development of laser-based precision spectroscopy, including the optical frequency comb technique"

Dr. George F. Smoot, Professor, the University of California, Berkeley, USA

Nobel Prize laureate in Physics, 2006

Prize motivation: " for work that helped cement the big-bang theory of how the universe was created "

Dr. Luc Montagnier,

Nobel Prize laureate in Physiology or Medicine, 2008

Prize motivation: " for his discovery of the human immunodeficiency virus (HIV)"

Dr. Ada E. Yonath, Director and Professor, Weizmann Institute of Science, Israel

Nobel Prize laureate in Chemistry 2009

Prize motivation: " for studies of the structure and function of the ribosome"

Dr. Akira Suzuki, Professor, Hokkaido University, Japan

Nobel Prize laureate in Chemistry, 2010

Prize motivation: " for palladium-catalyzed cross couplings in organic synthesis"

Dr. Dan Shechtman, Professor, Israel Institute of Technology, Israel

Nobel Prize laureate in Chemistry, 2011

Prize motivation: " for the discovery of quasicrystals"

Dr. Serge Haroche, Professor, École Normale Supérieure, France

Nobel Prize laureate in Physics 2012

Prize motivation: " for ground-breaking experimental methods that enable measuring and manipulation of individual quantum systems"

Dr. Thomas C. Südhof, Professor, Stanford University, USA

Nobel Prize in Physiology or Medicine, 2013

Prize motivation: "for their discoveries of machinery regulating vesicle traffic, a major transport system in our cells"

Dr. James E. Rothman, Professor, Yale University, USA
Nobel Prize laureate in Physiology or Medicine, 2013
Prize motivation: "for their discoveries of machinery regulating vesicle traffic, a major transport system in our cells"

Main Conference
Part One:
Opening Ceremony and Nobel Laureate Forum
Part Two:
Keynote Forum
Thematic Bio-economic Forums
Forum 1:
Global Bioeconomy Roadmap
Forum 5:
Bioscientific Education and Talents
Forum 2:
City Biotechnology Landscape
Forum 6:
Bio-Investment and Partnership
Forum 3:
Industrial Bio-Parks Development
Forum 7:
Bioenergy Development
Forum 4:
Academicians’ Peer Opinions
Forum 8:
Biodiversity and Eco-civilization
Hot Paper Briefing:
Focus on Current Academic Breaking Research
Focus D1: Young Scientist’s Research in                     Antibody Biology
Focus D2: Antibody Design and Discovery
Focus D3: Antibody Generation Technologies                    and Targets
Focus D4: Antibody-Drug Conjugates and                     Bispecific Antibodies
Focus D5: Antibody Optimization and                     Engineering
Focus D6: New Antibody Technologies and                     Antibody Formatse
Business Development
·Industrial Sponsored Symposia
·SME’s CEO Forum on Entrepreneurship
·Investor’s Forum
·Project Road Show
·Matchmaking and Biopartnering
·Round Table Discussion
·1-to-1 Networking
·Lunch Showcase
Career Development for Bioprofessionals
·Industrial Leader’s HR Briefing and Job Briefing
·Biotech Industrial Job Fair
·Career Fair for Faculty and Post-doc Positions
·Training Course: How to Enhance Your Career Growth
Posters and EXPO

·Posters Sessions
·Product and Technology Exhibition

Why Reserve a Booth at ica-2014

·Meet face to face with key leaders in the field of protein and peptide
science and technology
·Explore new business opportunities both at home and abroad
·Spotlight your advanced technologies and their scientific and commercial applications
·Have the opportunity to network with those attending the conference in the exhibition hall
Social Events
·Culture Activities-Art Performance and Show
·Cocktail Social Networking
·City Tour As Requested
·Field Trip to Universities/Industries, and Networking Tour

Copyright © 2013. BIT Congress Inc.
Tel: 0086-411-84575669 ext 860 Fax: 0086-411-84799629 Email: